Follow Us:   

Applying Real World Evidence to Patient Care: NOAC Therapy for Atrial Fibrillation

Post Activity Resource

Thank you for attending this Pri-Med Online VER Webinar

As part of the program, Pri-Med has developed a quick Post-Activity resource to further your education on this topic in the form of podcast with one of the speakers from the webinar Dr. Ty J. Gluckman.

We encourage you to listen to quick 5 minute podcast here:

Aired on August 15, 2019 | 12:00 PM - 1:00 PM ET
 Live Webinar Video

Program Description:

Evidence from real world studies on the effectiveness, safety, and dosing of non-vitamin-K oral anticoagulants (NOACs) provides crucial insights on the treatment of patients with atrial fibrillation (AF). In this program, you will learn to assess the quality of these studies and compare the relevance, validity, and utility of the results to those of randomized controlled trials. Judicial assessment and appropriate incorporation of real world data into clinical practice can improve the care of your patients with AF and other conditions.

Learning Objectives:

  • Explain the differences between RCTs and real world studies, including the study setting, type of data being evaluated, and utility of the results
  • Describe RWD methodology and assess the quality of real world studies to determine their relevance and usefulness in clinical practice
  • Describe recent real world studies about NOAC effectiveness, safety, and dosing, and recognize how these studies can inform clinical care


  • CFPC members who complete any CME program accredited by the AMA can claim the equivalent number of Certified Mainpro+ credits.
  • pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • pmiCME designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:

Supported by an educational grant from the Bristol-Myers Squibb and Pfizer Alliance.


Lawrence Blonde, MD, FACP, MACE

Director, Ochsner Diabetes Clinical Research Unit, Frank Riddick Diabetes Institute, Department of Endocrinology, Ochsner Medical Center, New Orleans, LA. Full Bio

Gluckman Ty

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR Full Bio

Kushner Pamela

Pamela Kushner, MD, FAAFP

Clinical Professor, Director, Kushner Wellness, UC Irvine Medical Center, Orange, CA. Full Bio